Chemexpress(SH:688131) Zheng Quan Zhi Xing·2025-07-01 16:30Core Viewpoint - The Shanghai Haoyuan Pharmaceutical Co., Ltd. is holding its fourth extraordinary general meeting of shareholders in 2025 to discuss significant governance changes, including the cancellation of the supervisory board and amendments to the company's articles of association [6][7]. Group 1: Meeting Procedures - The meeting will verify the identity of attendees and restrict entry to authorized personnel only [2]. - Shareholders must arrive 30 minutes prior to the meeting for registration and must present valid identification [2]. - Attendees are required to maintain order during the meeting and adhere to the established rules for speaking and voting [3][5]. Group 2: Agenda Items - The meeting will address two main proposals: the cancellation of the supervisory board and the revision of the company's articles of association [6][7]. - The second proposal includes 13 sub-proposals aimed at improving corporate governance and operational efficiency [8]. Group 3: Voting and Decision-Making - Voting will be conducted through a combination of on-site and online methods, with specific time slots designated for each [5][6]. - The results of the voting will be announced by the meeting host after the counting process is completed [5][6]. Group 4: Governance Changes - The proposal to cancel the supervisory board is based on recent legal amendments and aims to enhance the board's oversight capabilities through the audit committee [7]. - The company plans to revise its governance structure in accordance with the new legal framework and operational needs [8][9].